Summary
Christopher Maher is a translational oncology leader and physician-scientist with nine years of focused experience directing molecular and therapeutic programs for solid tumors at Washington University School of Medicine and the Alvin Siteman Cancer Center. He combines academic rigor—as a Professor and Co-Director of the Molecular Oncology Section—with hands-on program leadership as Co-Leader of the Solid Tumor Therapeutics Program and former Assistant Director of the McDonnell Genome Institute. Trained in biomedical engineering (BS, Cornell; PhD, Cold Spring Harbor Laboratory) and forged through postdoctoral work, he integrates genomics, therapeutic development, and clinical collaboration to accelerate cancer research into patient impact. Based in Missouri, he runs an active lab (maherlab.com) that emphasizes multidisciplinary translation and novel therapeutic strategies. An often-overlooked strength is his sustained institutional leadership across research, genomics infrastructure, and clinical program building—bridging discovery pipelines from sequencing to therapeutic testing.
9 years of coding experience
BS, Biomedical/Medical Engineering, BS, Biomedical/Medical Engineering at Cornell University
Doctor of Philosophy (PhD), Biomedical/Medical Engineering, Doctor of Philosophy (PhD), Biomedical/Medical Engineering at Cold Spring Harbor Laboratory